Clinical Trial Update: Effect of Autogenous Demineralized Dentin as a Bone Graft Substitute in Management of Periodontal Intrabony Defects [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating autogenous demineralized dentin as a bone graft substitute for managing periodontal intrabony defects.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intrabony Defect
• Periodontal Disease

Drugs mentioned

• Autogenous demineralized dentin

Snippet

Sponsor: Cairo University | Conditions: Intrabony Defect | Phase 3 | Status: UNKNOWN